After a positive FDA panel for Aimmune’s and FDA decision looming, we will discuss the commercial potential of Palforzia. NOTE: Call will have a proprietary survey, run by SI, of high volume pediatric allergists/immunologists available.
The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive amounts of vaccine.
Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future.
No one should be forced to choose between the community they call home and being able to access the care their children need.
Genetic evidence of the H5N1 bird flu virus was found in grocery store milk in the United States this week, according to the Food and…
New research from academic hospitals reveals significant limitations of large language models (LLMs) in medical settings.
The USDA will instead enforce a limit on added sugars in chocolate and other flavored milk served in schools starting in the fall of 2025.
A new Science paper from the Baker lab details a novel method for quickly compiling a large library of macrocycle drug candidates.
“This is not a solution for all South African patients” and is “likely to widen the disparity between rich and poor,” advocates complained.
The FTC’s noncompete ban could force sweeping changes in the health care industry, but implementation of the rule will almost certainly be held up by…
Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved.
